ClinConnect ClinConnect Logo
Search / Trial NCT07093983

Comparing Two Therapies to Improve Arm Function After Stroke

Launched by UNIVERSITY OF LAHORE · Jul 22, 2025

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

Coupling Rehabilitation Cimt Stroke Impairment

ClinConnect Summary

This clinical trial is studying two different therapy approaches to help improve arm and hand function in people who have weakness after a stroke. The goal is to see which therapy—either constraint-induced movement therapy (CIMT), where the stronger arm is gently restricted to encourage use of the weaker arm, or coupling rehabilitation combined with regular physical therapy—works better to restore movement and help with daily activities like eating or dressing. Participants will receive 12 weeks of therapy and will be tested before, during, and after the treatment to measure their progress.

People who might be eligible for this study are adults between 40 and 65 years old who have had a stroke recently and experience moderate arm weakness. To join, participants need to have certain levels of arm movement and hand skills based on specific tests, and they should not have serious heart problems, organ failure, recent injuries to their arms, or memory and thinking problems unrelated to the stroke. If accepted, participants can expect to be randomly assigned to one of the two therapies and attend regular sessions for 3 months. The results of this study may help improve rehabilitation methods for stroke survivors in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: •Age 40-65 years old
  • Patients suffering from Sub acute stroke
  • Motor function score at Fugl-Meyer Assessment between 40-60
  • Fine motor assessment at Box and Block Test\<20
  • * ADL's assessment at Motor Activity Log:
  • Amount of use scale\<2.5 Quality of movement scale\<3
  • -
  • Exclusion Criteria:
  • Individuals suffering from unstable angina, symptomatic heart failure, or uncontrolled hypertension
  • Physician determined unstable cardiovascular conditions
  • The patient has been diagnosed as having organ failure, including the heart, kidneys, and lungs
  • Patients with any traumatic musculoskeletal injury to upper limbs
  • Individuals who are experiencing cognitive impairment as a result of neurological conditions other than stroke.

About University Of Lahore

The University of Lahore is a leading academic institution dedicated to advancing healthcare research and education. With a robust commitment to scientific inquiry, the university sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging its state-of-the-art facilities and interdisciplinary expertise, the University of Lahore collaborates with healthcare professionals and researchers to conduct innovative studies that address pressing health challenges. Through its clinical trial initiatives, the university strives to contribute to evidence-based practices and foster advancements in clinical care.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Maryam Shabbir, PH.D. PT

Principal Investigator

The University of Lahore

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported